what are the side effects of semaglutide shots 20 Ozempic and Wegovy You Should Know About side effects to semaglutide injections

All regulatory agencies are awaiting Phase 3 data Phase 2 results: Up to 24.2% weight loss at 48 weeks, the highest efficacy data for any GLP-1 class medication Commercial launch timeline: FDA submission expected 2026-2027, with 6-12 month review period International rollout: EMA (Europe) and TGA (Australia) typically follow FDA approval within 6-18 months Is retatrutide available

This is not the case for injectable tirzepatide

W.BradyS

GLP-1 acts by inhibiting key cytokines such as TNF- , IL-17 , IL-23 and IL-22 , molecules that are strongly implicated in the skin inflammation seen in diseases such as psoriasis and hidradenitis suppurativa

Research compounds disclaimer